logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jian-Qing Mi

Shanghai Jiaotong University School of Medicine
H指数:32
被引数:4,857

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A First-In-Human Phase 1 Study of a Novel BCMA×CD3 Bispecific T Cell Engager EMB-06 in Relapsed or Refractory Multiple Myeloma

一项EMB-06新型BCMA×CD3双特异性T细胞衔接剂在复发或难治性多发性骨髓瘤中的首次人体I期研究

American Journal of Hematology
IF9.9
2025-10-140
OAAI
Peter T. Tan; Li Bao; Qingsong Yin; Chunrui Li; Sorab Jehangir Shavaksha; Henry Miles Prince; Zhen Cai; Shan Gao; Qian Wang; Di Wang; Yi Li; Mingfei Zhang; Qiumei Deng; Qiaoyang Lu; Chengjun Jiang; Fang Ren; Danqing Wu; Shuqi Zeng; Yonghong Zhu; Yi Tao; Yuanfang Liu; Jian-Qing Mi
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study

中国急性白血病亚型在不同年龄组的发病率、死亡率和生存率：一项基于人群癌症登记的分析和队列研究

The Lancet Haematology
IF0
2025-10-060
PRE
Wei Yin; Xiaoyu Yan; Jiaoyang Cai; Bingfeng Han; Peng Yin; Gang Lu; Wenyan Cheng; Jianan Zhang; Huiyi Wu; Jiaqi Ren; Pengyu Ren; Zifang Zhou; Haibo Wang; Ying Shi; Lanxia Gan; Depei Wu; Jie Jin; Yongping Song; Zhongxing Jiang; Xiaojing Yan; Ting Niu; Yu Hu; Fei Li; Sujun Gao; Tao Cheng; Jianxiang Wang; Xi Zhang; Xiaojun Huang; Qifa Liu; Xiaoyu Zhu; Pengcheng He; Yuqing Chen; Tonghua Yang; Jianyong Li; Xudong Wei; Yongrong Lai; Jishi Wang; Jinsong Yan; Jie Yu; Xiaofan Zhu; Weiqun Xu; Yufeng Liu; Ju Gao; Hua Jiang; Yongzhi Zheng; Hua Wang; Yunyan He; Yongjun Fang; Shuhong Shen; Jing Chen; Bing Chen; Sujiang Zhang; Yang Shen; Jin Wang; Jianqing Mi; Weili Zhao; Hao Zhang; Maigeng Zhou; Wenqiang Wei; Jie He; Zhu Chen; Sai-Juan Chen
PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia
NATURE COMMUNICATIONS
IF15.7
2024-11-080
OAAI
Beck, Dominik; Cao, Honghui; Tian, Feng; Huang, Yizhou; Jiang, Miao; Zhao, Han; Tai, Xiaolu; Xu, Wenqian; Kosasih, Hansen J.; Kealy, David J.; Zhao, Weiye; Taylor, Samuel J.; Couttas, Timothy A.; Song, Gaoxian; Chacon-Fajardo, Diego; Walia, Yashna; Wang, Meng; Dowle, Adam A.; Holding, Andrew N.; Bridge, Katherine S.; Zhang, Chao; Wang, Jin; Mi, Jian-Qing; Lock, Richard B.; de Bock, Charles E.; Jing, Duohui
A Hiplot-Based Web Application for the Rapid Prediction of Adult BCR::ABLI-Positive and BCR::ABLI-like B-Cell Precursor Acute Lymphoblastic Leukemia

基于Hiplot的Web应用程序，用于成人BCR::ABLI阳性及BCR::ABLI样B细胞前体急性淋巴细胞白血病的快速预测

BLOOD
IF23.1
2024-11-050
PRE
Li, Jianfeng; Yan, Yuchen; Wang, Cheng; Liu, Weiyang; Yan, Han; Zhao, Lingling; Weng, Xiangqin; Zhu, Yongmei; Ren, Jiayi; Peng, Lijun; Zhang, Jiaojiao; Liu, Yuanfang; Zhang, Weiping; Xu, Jie; Jing, Duohui; Mi, Jian-Qing; Wang, Jin
Low-Risk Group Identified By a Refined Prognostic System Integrating Both IKZF1 plus genotyping and MRD Assessment in Adult BCR::ABL1-Positive Acute Lymphoblastic Leukemia

由整合IKZF1 plus基因分型和MRD评估的优化预后系统识别的低风险组，在成人BCR::ABL1阳性急性淋巴细胞白血病中的应用

BLOOD
IF23.1
2024-11-050
PRE
Wang, Cheng; Li, Jianfeng; Liu, Weiyang; Yan, Han; Yan, Yuchen; Zhao, Lingling; Ren, Jiayi; Peng, Lijun; Zhang, Jiaojiao; Liu, Yuanfang; Weng, Xiangqin; Zhu, Yongmei; Zhang, Weiping; Xu, Jie; Jing, Duohui; Mi, Jian-Qing; Wang, Jin
Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study

CAR T细胞持久性对复发/难治性多发性骨髓瘤临床结局的影响：Fumanba-1二期研究的见解

BLOOD
IF23.1
2024-11-051
PRE
Li, Chunrui; Zou, Dehui; Wang, Di; Fang, Baijun; Huang, He; Li, Jianyong; Chen, Bing; Liu, Jing; Zhang, Xi; Dong, Yujun; Hu, Kai; Liu, Peng; Mi, Jianqing; Ding, Kaiyang; Li, Zhenyu; Dong, Qie; Zhang, Fuyuan; Hu, Guang; Qiu, Lu-Gui
Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

每周 Selinexor、Bortizomib 和 Dexamethasone (SVd) 与每周两次 Bortizomib 和 Dexamethasone (Vd) 在中国复发性和难治性多发性骨髓瘤 (RRMM) 患者中的比较：Bench 研究的初步分析

BLOOD
IF23.1
2024-11-050
PRE
Lu, Jin; Geng, Liangquan; Chen, Lijuan; Liu, Peng; Zhong, Yuping; Liu, Zhuogang; Xia, Zhongjun; Mi, Jianqing; Li, Chunrui; Zhang, Xi; He, Yanjuan; Wei, Yongqiang; Fang, Baijun; Li, Fei; Cai, Zhen; Wang, Yafei; Huang, Dongping; Liu, Hong; Hou, Ming; Fu, Rong; Du, Xin; Fang, Xiaosheng; Zeng, Qingshu; Gao, Wen; Wang, Wei; Chang, Chunkang; Ouyang, Guifang; Liu, Jing; Weng, Jianyu; Huang, Xiaobing; Yu, Yang; Guo, Zhi; Zhao, Jun; Hou, Jian
Recommendations for the timing, dosage, and usage of corticosteroids during cytokine release syndrome (CRS) caused by chimeric antigen receptor (CAR)-T cell therapy for hematologic malignancies
CHINESE MEDICAL JOURNAL
IF7.3
2024-11-050
OAAI
Tu, Sanfang; Luo, Xiu; Mei, Heng; Hu, Yongxian; Liu, Yang; Li, Ping; Zou, Dehui; Niu, Ting; Xu, Kailin; Zhang, Xi; Qiu, Lugui; Gao, Lei; Gao, Guangxun; Zhang, Li; Feng, Yimei; Wang, Ying; Zhao, Mingfeng; Mi, Jianqing; Hou, Ming; Yang, Jianmin; Huang, He; Wang, Jianxiang; Hu, Yu; Zhao, Weili; Wu, Depei; Ma, Jun; Li, Yuhua; Qian, Wenbin; Huang, Xiaojun; Han, Weidong; Liang, Aibin
Isatuximab Plus Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus Vrd in Chinese Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant: IMROZ Subgroup Analysis

Isatuximab 联合硼替佐米、来那度胺和地塞米松（Isa-VRd）与 VRd 方案对比，适用于不适合移植的中国新诊断多发性骨髓瘤患者的 IMROZ 亚组分析

BLOOD
IF23.1
2024-11-050
PRE
An, Gang; Liu, Zhuogang; Jin, Jie; Cai, Zhen; Li, Wei; Xia, Zhongjun; Cen, Xinan; Hu, Yu; Mi, Jian-Qing; Jing, Hongmei; Zhan, Rong; Qu, Xiaoyan; Du, Xin; Gao, Dan; Zhao, Liang; Qiu, Lugui
Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial

LCAR-B38M car-t细胞治疗后复发或难治性多发性骨髓瘤患者的长期缓解和生存: LEGEND-2试验的5年随访

JOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
2024-04-2410
OAAI
Xu, Jie; Wang, Bai-Yan; Yu, Shan-He; Chen, Shi-Jun; Yang, Shuang-Shuang; Liu, Rui; Chen, Li-Juan; Hou, Jian; Chen, Zhu; Zhao, Wan-Hong; He, Ai-Li; Mi, Jian-Qing; Chen, Sai-Juan

研究方向

暂未获取到该数据
陈
陈赛娟
H 指数:73论文数:458被引数:2.4万
刘
刘元方
H 指数:59论文数:326被引数:1.6万
许
许捷
H 指数:28论文数:81被引数:3,849
朱陈 封面图
朱陈
H 指数:75论文数:444被引数:2.1万
Y
Yongmei Zhu
H 指数:19论文数:93被引数:3,422
李
李俊敏
H 指数:42论文数:391被引数:7,458
D
Duohui Jing
H 指数:16论文数:73被引数:1,667
S
Shiwei Jin
H 指数:7论文数:28被引数:307
X
Xiangqin Weng
H 指数:20论文数:105被引数:2,442
J
Jin Wang
H 指数:17论文数:67被引数:1,558